Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5268429
Max Phase: Preclinical
Molecular Formula: C37H44O6
Molecular Weight: 584.75
Associated Items:
ID: ALA5268429
Max Phase: Preclinical
Molecular Formula: C37H44O6
Molecular Weight: 584.75
Associated Items:
Canonical SMILES: C=C(C)/C=C/[C@]1(C)C=CC2=C(O1)C(CC=C(C)C)=C1O[C@]34C(=C[C@@H]5C[C@H]3C(C)(C)O[C@@]4(CC=C(C)C)C5=O)C(=O)[C@@H]1C2O
Standard InChI: InChI=1S/C37H44O6/c1-20(2)10-11-25-31-24(14-16-35(9,41-31)15-12-21(3)4)29(38)28-30(39)26-18-23-19-27-34(7,8)43-36(33(23)40,17-13-22(5)6)37(26,27)42-32(25)28/h10,12-16,18,23,27-29,38H,3,11,17,19H2,1-2,4-9H3/b15-12+/t23-,27+,28+,29?,35-,36+,37-/m1/s1
Standard InChI Key: KJZDHWJJMOTXDN-SFQHMDSXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 584.75 | Molecular Weight (Monoisotopic): 584.3138 | AlogP: 6.71 | #Rotatable Bonds: 6 |
Polar Surface Area: 82.06 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 13.58 | CX Basic pKa: | CX LogP: 5.12 | CX LogD: 5.12 |
Aromatic Rings: 0 | Heavy Atoms: 43 | QED Weighted: 0.28 | Np Likeness Score: 2.78 |
1. Santos CMM, Freitas M, Fernandes E.. (2018) A comprehensive review on xanthone derivatives as α-glucosidase inhibitors., 157 [PMID:30282319] [10.1016/j.ejmech.2018.07.073] |
Source(1):